Isabelle Vanden Bempt

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization

Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium

Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes

Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusion

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies

The <i>EGFRvIII</i> transcriptome in glioblastoma: A meta-omics analysis

Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D

Comprehensive targeted next‐generation sequencing approach in the molecular diagnosis of <scp>gastrointestinal stromal tumor</scp>